|
| Home - Fachinformation zu Stalevo 50/12.5/200 mg - Änderungen - 30.01.2026 | |
| 4 Änderungen an Fachinfo Stalevo 50/12.5/200 mg |
- DC-Hemmer(n = 85) emmer(n = 86) - + DC-Hemmer (n = 85) emmer (n = 86)
- Entacapon(n = 103) Placebo(n = 102) Differenz-Baseline** (%) 60.0 ± 15.2 60.8 ± 14.0 -Woche 8–24** (%) 66.8 ± 14.5 62.8 ± 16.80 4.5 % (0 h 35 min)VI 95 % 0.93 %, 7.97 %- + Entacapon (n = 103) Placebo (n = 102) Differenz
- +Baseline** (%) 60.0 ± 15.2 60.8 ± 14.0
- +Woche 8–24** (%) 66.8 ± 14.5 62.8 ± 16.80 4.5 % (0 h 35 min)VI 95 % 0.93 %, 7.97 %
|
|
|
